Correlation Between Olema Pharmaceuticals and Relmada Therapeutics

Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and Relmada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and Relmada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Olema Pharmaceuticals and Relmada Therapeutics, you can compare the effects of market volatilities on Olema Pharmaceuticals and Relmada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of Relmada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and Relmada Therapeutics.

Diversification Opportunities for Olema Pharmaceuticals and Relmada Therapeutics

0.46

Correlation Coefficient

Olema Pharmaceuticals  Relmada Therapeutics

Very weak diversification

The 3 months correlation between Olema and Relmada is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and Relmada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relmada Therapeutics and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with Relmada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relmada Therapeutics has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and Relmada Therapeutics go up and down completely randomly.

Pair Corralation between Olema Pharmaceuticals and Relmada Therapeutics

Given the investment horizon of 90 days Olema Pharmaceuticals is expected to under-perform the Relmada Therapeutics. In addition to that, Olema Pharmaceuticals is 1.01 times more volatile than Relmada Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Relmada Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest  255.00  in Relmada Therapeutics on September 4, 2024 and sell it today you would earn a total of  74.00  from holding Relmada Therapeutics or generate 29.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Olema Pharmaceuticals  vs.  Relmada Therapeutics

Olema Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Olema Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Relmada Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Relmada Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting primary indicators, Relmada Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Olema Pharmaceuticals and Relmada Therapeutics

The main advantage of trading using opposite Olema Pharmaceuticals and Relmada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, Relmada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relmada Therapeutics will offset losses from the drop in Relmada Therapeutics' long position.

The idea behind Olema Pharmaceuticals and Relmada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.